Navigation Links
STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year
Date:6/28/2010

ANTONY, France, June 28, 2010 /PRNewswire-FirstCall/ -- After having announced positive results for the first year of its phase IIb/III clinical trial (VO 57.07) conducted on Actair(R) sublingual allergen immunotherapy tablets in allergic rhinitis triggered by house dust mites in April 2009, Stallergenes S.A. today announces the results of the second year of this study.

Following this first year which demonstrated positive results for both the dosages tested (300 IR[1] and 500 IR) and which is key for the marketing authorization application, the second year of the study involved an exploratory evaluation of the persistence of the therapeutic effect of Actair(R) in the following year. Out of the 509 patients originally included in the study, 397 participated until the end of the second year. The primary endpoint for this second year was the Average Adjusted Symptom Score (AAdSS)[2] measured one year after the end of treatment.

The results of this second year demonstrate not only that the efficacy of Actair(R) persists well beyond the first six months after treatment is stopped but also that the size effect is globally equivalent to that observed in the first year. Thus in the main assessment period for the efficacy endpoint (between 10 and 12 months after the discontinuation of treatment), both active groups demonstrated a persistent effect of the treatment, with a statistically significant difference for the AAdSS versus placebo [(p=0.0342) for the 300 IR dosage; (p=0.0229) for the 500 IR dosage], still with no difference between the two treated groups.

This study is a world first in that, for the first time, it indisputably demonstrates the persistence of the effect of sublingual allergen immunotherapy in perennial allergic rhinitis triggered
'/>"/>

SOURCE Stallergenes
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
2. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
3. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
4. FDA Approves New Device for Adults with Severe and Persistent Asthma
5. Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
6. Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
7. Study Analyzed SYMBICORT(R) in Children with Persistent Asthma
8. New Data Demonstrated Efficacy and Safety of Initial Combination Therapy with Welchol(R) (colesevelam HCl) and Metformin in Drug-Naive Adult Type 2 Diabetes Patients
9. New Data Demonstrate Safety, Efficacy of Stereotaxis for Patients with AFIB, VT and Congenital Defects
10. FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
11. The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Novastem, a ... its first patient in its study for ischemic ... American Stroke Association, ischemic strokes account for 87 ... enroll qualified patients in the study, entitled "Internal ... of Allogeneic Mesenchymal Stem Cells and Intrathecal Administration ...
(Date:12/24/2014)... , Dec. 24, 2014 Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today that on December 24, 2014 ... The Company raised approximately $2.3 million ... to use the net proceeds from the offering ...
(Date:12/24/2014)... and LONDON , December ... orthopedic industry are expected to grow at an average ... terms of value and volume. Hip, knee and spine ... world while in emerging economies they have a lower ... are challenging the use of composites. Non-metallic orthopedic devices ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
... , Jan. 19 Perrigo Company (Nasdaq: PRGO ; ... quarter fiscal 2010 on Tuesday, February 2, 2010 at approximately ... at 10:00 a.m. (ET) hosted by Joseph C. Papa ... be available live via webcast to interested parties on the Perrigo website ...
... Pa. , Jan. 19 Recognized as one ... , St. Louis Children,s Hospital in St. Louis is ... of a SOMATOM® Definition AS computed tomography (CT) scanner from Siemens ... which intelligently adapts, on the fly, to the patient, for aiding ...
Cached Medicine Technology:Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010 2Siemens Delivers Complete Dose Protection to St. Louis Children's Hospital 2Siemens Delivers Complete Dose Protection to St. Louis Children's Hospital 3Siemens Delivers Complete Dose Protection to St. Louis Children's Hospital 4
(Date:12/25/2014)... 25, 2014 Residents at ... recently showed their generous spirit by providing holiday ... County Parenting Network- Grandparents Raising Grandchildren program. , ... around the largest Christmas tree on the campus ... by residents of the Abernethy Village Association (AVA). ...
(Date:12/24/2014)... Over 700 toys, that’s what ... That is 700 smiling little faces this holiday that ... $6000 in monetary donations was given to the various ... expenses they incur through the year. Some of the ... Child's Haven , Shrine's Children's Hospitals, Toys for Tots ...
(Date:12/24/2014)... York (PRWEB) December 24, 2014 Risperdal ... in a mass tort litigation currently underway in Pennsylvania’s ... As of December 24, 2014, court documents indicate ... on behalf of individuals who developed gynecomastia (male breast ... Data from the Court indicates that this represents an ...
(Date:12/24/2014)... 2014 Today, UWDress.com, the famous women’s dress ... gowns, and launched a site-wide wedding gown promotion. ... gowns in a more unexpected way, the collection should be ... in the global market, and they are available with custom ... offered at discounted prices, up to 75% off; most of ...
(Date:12/24/2014)... BambooIndustry.com a famous bamboo flooring company offering bamboo flooring ... announces its multiple layer bamboo panel board collection , ... , Bamboo panel is the product made from 100 ... board features high quality selective bamboo and eco-friendly adhesives ... panel consists of multiple layers of bamboo. , According ...
Breaking Medicine News(10 mins):Health News:Retirement Community Residents Make Impact During Holiday Season 2Health News:AlignLife Donates Over 700 Toys This Year 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Bamboo Flooring Company Bambooindustry.com Introduces Its Multiple Layer Bamboo Panel Board Collection 2
... ... exposure is still being written. , ... New York, NY (PRWEB) April 15, 2010 -- Although most asbestos use was banned ... ago in dozens of household and building products, says Joseph W. Belluck, a New York ...
... ... , ... 15, 2010 -- A recent survey by BusinessProcessGuidance.com of 286 senior executives found that the ... it done. Among the study’s key findings: knowledge workers not only have more to do, ...
... ... will not keep pace with an increasing number of Alzheimer’s patients forecast in the ... help those suffering from this disease and their stressed-out families. , ... Omaha, NE (PRWEB) April 15, 2010 ...
... WESTCHESTER, IL - A study in the April 15 issue of ... a video game before bedtime has only a mild effect on ... playing a stimulating video game it took adolescents a median of ... the three minutes it took them to fall asleep after passively ...
... for the treatment of men with an aggressive form ... concluded that the targeted therapy MDV3100 is safe and ... for its poor prognosis and limited treatment options. The ... appears early online and in an upcoming edition of ...
... ICRW Gender ... ... in three women are expected to experience physical or sexual violence from a man at least ... is to involve men and boys in prevention efforts and to design public policies, and evidence-based ...
Cached Medicine News:Health News:Asbestos Exposure Continues to Scar U.S. Workers and Their Families, New York Attorney Says 2Health News:Asbestos Exposure Continues to Scar U.S. Workers and Their Families, New York Attorney Says 3Health News:BusinessProcessGuidance.com Survey Exposes a Knowledge Worker Productivity Gap 2Health News:Home Care Businesses Fill Void As Alzheimer's Care Units Decline 2Health News:Home Care Businesses Fill Void As Alzheimer's Care Units Decline 3Health News:Playing a video game before bedtime has only a mild effect on adolescent sleep 2Health News:Playing a video game before bedtime has only a mild effect on adolescent sleep 3Health News:New targeted therapy effective in treating advanced prostate cancer 2Health News:New targeted therapy effective in treating advanced prostate cancer 3Health News:ICRW Says to Stop Violence against Women, Aim National Policies at Men 2Health News:ICRW Says to Stop Violence against Women, Aim National Policies at Men 3
Anatomically designed 3 cervical foam collar...
This model utilizes the Malibu Soft Cervical Collar with a Thoracic Extension....
... Occipital Mandibular Immobilizer) A completely adjustable ... or hypertension positioning and immobilization. Offers ... Philadelphia™ collar and a halo-type brace.,Mandibular ... Removable chin plate allows for patient ...
... Wrap® Economy Universal Cervical ... with synthtic white stockinette ... for flexion or extension. ... air dry. 3"H.,Universal size ...
Medicine Products: